A detailed history of Primecap Management CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Primecap Management CO holds 41,980,045 shares of AZN stock, worth $2.81 Billion. This represents 2.45% of its overall portfolio holdings.

Number of Shares
41,980,045
Previous 42,597,235 1.45%
Holding current value
$2.81 Billion
Previous $3.32 Billion 1.54%
% of portfolio
2.45%
Previous 2.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$76.67 - $87.62 $47.3 Million - $54.1 Million
-617,190 Reduced 1.45%
41,980,045 $3.27 Billion
Q2 2024

Aug 09, 2024

SELL
$66.81 - $80.83 $23.2 Million - $28.1 Million
-347,940 Reduced 0.81%
42,597,235 $3.32 Billion
Q1 2024

May 13, 2024

SELL
$61.03 - $69.57 $2.56 Million - $2.91 Million
-41,900 Reduced 0.1%
42,945,175 $2.91 Billion
Q4 2023

Feb 09, 2024

SELL
$61.89 - $69.28 $55.8 Million - $62.5 Million
-902,290 Reduced 2.06%
42,987,075 $2.9 Billion
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $12.2 Million - $13.5 Million
-187,935 Reduced 0.43%
43,889,365 $2.97 Billion
Q2 2023

Aug 11, 2023

SELL
$69.91 - $75.81 $91.8 Million - $99.5 Million
-1,312,557 Reduced 2.89%
44,077,300 $3.15 Billion
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $25.5 Million - $28.9 Million
403,017 Added 0.9%
45,389,857 $3.15 Billion
Q4 2022

Feb 13, 2023

SELL
$54.21 - $70.44 $34 Million - $44.2 Million
-627,270 Reduced 1.38%
44,986,840 $3.05 Billion
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $10.6 Million - $27.1 Million
-199,710 Reduced 0.44%
45,614,110 $2.5 Billion
Q2 2022

Aug 11, 2022

SELL
$59.26 - $71.14 $29.9 Million - $35.9 Million
-504,060 Reduced 1.09%
45,813,820 $3.03 Billion
Q1 2022

May 11, 2022

SELL
$55.72 - $67.12 $20.8 Million - $25 Million
-372,620 Reduced 0.8%
46,317,880 $3.07 Billion
Q4 2021

Feb 11, 2022

SELL
$54.02 - $63.83 $85.1 Million - $101 Million
-1,575,750 Reduced 3.26%
46,690,500 $2.72 Billion
Q3 2021

Nov 12, 2021

SELL
$55.56 - $60.79 $24.3 Million - $26.6 Million
-437,943 Reduced 0.9%
48,266,250 $2.9 Billion
Q2 2021

Aug 10, 2021

SELL
$48.42 - $60.18 $58.5 Million - $72.8 Million
-1,209,033 Reduced 2.42%
48,704,193 $2.92 Billion
Q1 2021

May 14, 2021

SELL
$47.16 - $54.44 $9.23 Million - $10.7 Million
-195,720 Reduced 0.39%
49,913,226 $2.48 Billion
Q4 2020

Feb 08, 2021

SELL
$48.52 - $58.02 $67.4 Million - $80.6 Million
-1,389,115 Reduced 2.7%
50,108,946 $2.5 Billion
Q3 2020

Nov 13, 2020

SELL
$53.07 - $61.1 $115 Million - $132 Million
-2,163,676 Reduced 4.03%
51,498,061 $2.82 Billion
Q2 2020

Aug 13, 2020

SELL
$43.1 - $55.31 $128 Million - $165 Million
-2,979,584 Reduced 5.26%
53,661,737 $2.84 Billion
Q1 2020

May 14, 2020

SELL
$37.79 - $51.33 $80.9 Million - $110 Million
-2,141,045 Reduced 3.64%
56,641,321 $2.53 Billion
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $1.99 Million - $2.36 Million
-46,830 Reduced 0.08%
58,782,366 $2.93 Billion
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $31.5 Million - $35.7 Million
785,065 Added 1.35%
58,829,196 $2.62 Billion
Q2 2019

Aug 14, 2019

BUY
$37.28 - $41.68 $63.4 Million - $70.9 Million
1,700,975 Added 3.02%
58,044,131 $2.4 Billion
Q1 2019

May 14, 2019

BUY
$35.49 - $43.02 $6.93 Million - $8.4 Million
195,230 Added 0.35%
56,343,156 $2.28 Billion
Q4 2018

Feb 12, 2019

BUY
$36.86 - $41.49 $27.6 Million - $31.1 Million
748,640 Added 1.35%
56,147,926 $2.13 Billion
Q3 2018

Nov 13, 2018

BUY
$34.76 - $39.72 $82.2 Million - $93.9 Million
2,364,013 Added 4.46%
55,399,286 $2.19 Billion
Q2 2018

Aug 13, 2018

BUY
$34.55 - $37.05 $50.8 Million - $54.5 Million
1,469,835 Added 2.85%
53,035,273 $1.86 Billion
Q1 2018

May 14, 2018

BUY
$32.97 - $36.63 $183 Million - $203 Million
5,552,804 Added 12.07%
51,565,438 $1.8 Billion
Q4 2017

Feb 13, 2018

BUY
$32.09 - $34.78 $82.7 Million - $89.6 Million
2,577,104 Added 5.93%
46,012,634 $1.6 Billion
Q3 2017

Nov 13, 2017

BUY
$28.96 - $34.0 $1.26 Billion - $1.48 Billion
43,435,530
43,435,530 $1.47 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.